JPH04340445A - Method for discriminating false medicine - Google Patents
Method for discriminating false medicineInfo
- Publication number
- JPH04340445A JPH04340445A JP14065391A JP14065391A JPH04340445A JP H04340445 A JPH04340445 A JP H04340445A JP 14065391 A JP14065391 A JP 14065391A JP 14065391 A JP14065391 A JP 14065391A JP H04340445 A JPH04340445 A JP H04340445A
- Authority
- JP
- Japan
- Prior art keywords
- medicine
- drug
- light
- true
- discrimination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims abstract description 11
- 229940079593 drug Drugs 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 4
- 239000003962 counterfeit drug Substances 0.000 claims description 13
- 230000001678 irradiating effect Effects 0.000 claims description 4
- 230000008520 organization Effects 0.000 abstract description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 229940057344 bufferin Drugs 0.000 description 1
- 238000012850 discrimination method Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
Landscapes
- Investigating Materials By The Use Of Optical Means Adapted For Particular Applications (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
【０００１】0001
【産業上の利用分野】この発明は、偽薬の判別方法に関
する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for identifying fake drugs.
【０００２】0002
【従来の技術】偽薬の問題は医薬品の発達にしたがって
ますます大きな問題になってきている。しかも、薬は一
般的に外観的特徴が少ないので、包装や商標等を巧妙に
真似て作られると、偽薬を簡単に判別することは専門医
でも非常に困難である。勿論、先端の分析技術を駆使す
れば偽薬の判別を行える。しかし、個々の医療機関や薬
局で先端の分析技術をその都度用いることは不可能に近
い。また、専門の分析機関で判別させる、というシステ
ムも余り実用的でない。このような事情から、個々の医
療機関や薬局等で簡単に使える簡易な判別方法の開発が
急務となっている。BACKGROUND OF THE INVENTION The problem of fake drugs is becoming an increasingly serious problem as pharmaceuticals develop. Furthermore, since medicines generally have few external features, it is extremely difficult for even specialists to easily identify fake medicines if they are made by cleverly imitating packaging, trademarks, etc. Of course, using cutting-edge analysis technology, it is possible to distinguish between fake drugs. However, it is nearly impossible for individual medical institutions and pharmacies to use cutting-edge analysis technology on a case-by-case basis. Also, a system in which a specialized analytical organization makes the determination is not very practical. Under these circumstances, there is an urgent need to develop a simple discrimination method that can be easily used by individual medical institutions, pharmacies, etc.
【０００３】0003
【発明が解決しようとする課題】したがって、この発明
は、簡単な機器で容易に偽薬の判別を行える偽薬の判別
方法の提供を目的とする。SUMMARY OF THE INVENTION Accordingly, it is an object of the present invention to provide a method for discriminating fake drugs that can easily distinguish between fake drugs using a simple device.
【０００４】0004
【課題を解決するための手段】具体的には、特定波長域
または狭い波長域あるいは単色の判別用光を一種または
複数種、真薬の組成に対応させて選択し、この判別用光
を照射して得られた判別対象薬の外観像と、基準となる
真薬における基準外観像とを比較することにより偽薬を
判別する偽薬の判別方法を提供する。[Means for solving the problem] Specifically, one or more types of discrimination light in a specific wavelength range, a narrow wavelength range, or a single color are selected in accordance with the composition of the true medicine, and this discrimination light is irradiated. To provide a method for discriminating a fake drug, which discriminates a fake drug by comparing the appearance image of a drug to be discriminated obtained by this method with a reference appearance image of a true drug serving as a reference.
【０００５】この方法によると、例えば、真薬が蛍光性
成分を含むものであれば、例えば、紫外線を照射するこ
とにより、蛍光性成分による蛍光像が一定のパターンで
現れる。したがって、判別対象薬に紫外線を照射し、も
し基準となる真薬における所定のパターンの蛍光像が現
れなければ、判別対象薬が偽薬であることを判別できる
。According to this method, for example, if the true medicine contains a fluorescent component, a fluorescent image of the fluorescent component will appear in a certain pattern by irradiating it with ultraviolet light, for example. Therefore, when a drug to be determined is irradiated with ultraviolet rays and a fluorescence image of a predetermined pattern in a real drug serving as a reference does not appear, it can be determined that the drug to be determined is a placebo.
【０００６】このような方法は、単に、特定の光を照射
できる機能と、好ましくは数倍程度の拡大率での拡大観
察手段を整えるだけで十分に実行できるもので、個々の
医療機関や薬局等で簡単に使うことが可能である。[0006] Such a method can be carried out simply by providing a function for irradiating a specific light and a means for magnifying observation, preferably at a magnification of several times, and is suitable for individual medical institutions and pharmacies. etc. can be easily used.
【０００７】判別用光としては、紫外線の他に特定波長
域の光として赤外線、また、可視光領域においては狭い
波長域の光あるいは単色光が用いられるもので、これら
は、対象とする真薬について予め特定されているものを
用いることになる。In addition to ultraviolet rays, infrared rays are used as light in a specific wavelength range, and in the visible light range, light in a narrow wavelength range or monochromatic light is used as light for discrimination. Those specified in advance will be used.
【０００８】[0008]
【実施例】以下、この発明の実施例を説明する。この例
は、市販の錠剤薬であるバッファリン（商標）に適用し
た例で、真薬に対し紫外線を照射すると、一定のパター
ンの斑模様で蛍光を発する蛍光像が見られた。この蛍光
の斑模様は各錠ごとにほとんど同じであった。すなわち
、たとえ包装や商標等により真薬と同様にして売られて
いても、紫外線を照射した際に、真薬における前記のよ
うな蛍光の斑模様が現れない場合には、これを偽薬と判
別することができる。[Embodiments] Examples of the present invention will be described below. This example was applied to Bufferin (trademark), a commercially available tablet drug, and when the true drug was irradiated with ultraviolet rays, a fluorescent image was seen that emitted fluorescence in a fixed pattern. This fluorescent mottled pattern was almost the same for each tablet. In other words, even if the drug is sold in the same way as a real drug due to its packaging or trademark, if the fluorescent mottling pattern described above does not appear when exposed to ultraviolet light, it can be determined to be a fake drug. can do.
【０００９】[0009]
【発明の効果】この発明による偽薬の判別方法は、以上
説明したように、特定の光による判別用光を一種または
複数種、真薬の組成に対応させて選択し、この判別用光
を照射するだけで偽薬の判別を行うことができるので、
特定の光を照射できる機能と、好ましくは数倍程度の拡
大率での拡大観察手段を整えるだけで済み、個々の医療
機関や薬局等で簡単に使うことが可能であり、偽薬の排
除に大きな道を開くことができる。Effects of the Invention As explained above, the method for identifying a fake drug according to the present invention involves selecting one or more types of specific light for discrimination in accordance with the composition of the true drug, and irradiating this light for discrimination. You can tell whether it is a fake drug by simply doing the following:
All you need is a function that can irradiate a specific light and a means of magnifying observation, preferably at a magnification of several times, and it can be easily used at individual medical institutions and pharmacies, making it a great tool for eliminating fake drugs. can open the way.
Claims (1)
単色の判別用光を一種または複数種、真薬の組成に対応
させて選択し、この判別用光を照射して得られた判別対
象薬の外観像と、基準となる真薬における基準外観像と
を比較することにより偽薬を判別する偽薬の判別方法。Claim 1: One or more types of discrimination light in a specific wavelength range, narrow wavelength range, or monochromatic color are selected in accordance with the composition of the true drug, and the target drug obtained by irradiating the discrimination light with this discrimination light is used. A method for identifying fake drugs by comparing the appearance image with a standard appearance image of a genuine drug serving as a standard.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14065391A JPH04340445A (en) | 1991-05-17 | 1991-05-17 | Method for discriminating false medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14065391A JPH04340445A (en) | 1991-05-17 | 1991-05-17 | Method for discriminating false medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH04340445A true JPH04340445A (en) | 1992-11-26 |
Family
ID=15273652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14065391A Pending JPH04340445A (en) | 1991-05-17 | 1991-05-17 | Method for discriminating false medicine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH04340445A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004507759A (en) * | 2000-08-29 | 2004-03-11 | グラクソ グループ リミテッド | Method and system for real-time fluorescence measurement of trace elements |
-
1991
- 1991-05-17 JP JP14065391A patent/JPH04340445A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004507759A (en) * | 2000-08-29 | 2004-03-11 | グラクソ グループ リミテッド | Method and system for real-time fluorescence measurement of trace elements |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mironov et al. | Small cargo proteins and large aggregates can traverse the Golgi by a common mechanism without leaving the lumen of cisternae | |
| Fox | Attentional bias in anxiety: selective or not? | |
| Pittler et al. | Location bias in controlled clinical trials of complementary/alternative therapies | |
| Morimoto et al. | Spatial readout of visual looming in the central brain of Drosophila | |
| Friederici | The time course of syntactic activation during language processing: A model based on neuropsychological and neurophysiological data | |
| CN103649720B (en) | Bio-imaging method and system | |
| Hamer et al. | Multiple steps of phosphorylation of activated rhodopsin can account for the reproducibility of vertebrate rod single-photon responses | |
| NO973649L (en) | Computer-based multimedia medical database management system and user interface | |
| DE69835142D1 (en) | DEVICE FOR DETERMINING DISTURBING SUBSTANCES IN PLASMA | |
| Poirel et al. | Do you want to see the tree? Ignore the forest | |
| Day et al. | Sample size and power for comparing two or more treatment groups in clinical trials. | |
| Blumenfeld et al. | Evaluation of cellular mechanisms for modulation of calcium transients using a mathematical model of fura-2 Ca2+ imaging in Aplysia sensory neurons | |
| Van Arsdale et al. | Re‐examining the relationship between cranial deformation and extra‐sutural bone formation | |
| Beavogui et al. | Efficacy and safety of artesunate–amodiaquine and artemether–lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial | |
| Roberts et al. | Demonstration of the cell cycle positions of taxol-induced" asters" and" bundles" by sequential measurements of tubulin immunofluorescence, DNA content, and autoradiographic labeling of taxol-sensitive and-resistant cells. | |
| Scarrott | Optical polarization studies of astronomical objects | |
| JPH04340445A (en) | Method for discriminating false medicine | |
| Gaston et al. | Change deafness for real spatialized environmental scenes | |
| Azubuike | Principle of Responsibility to Protect: Implications for Sovereignty | |
| Balota et al. | Ambiguity resolution as a function of reading skill, age, dementia, and schizophrenia: The role of attentional control. | |
| Boccaccio et al. | Flash photolysis of caged compounds in the cilia of olfactory sensory neurons | |
| Dünser et al. | Evaluating visual search performance with a multi layer display | |
| Navakauskas | Epigenetics and Proteomics of Leukemia: A Synergy of Experimental Biology and Computational Informatics | |
| Braud | Nonevident psi | |
| Lawrence et al. | Delayed onsets are not necessary for generating distractor quitting thresholds effects in visual search |